SAW
ABBV icon

Signal Advisors Wealth’s AbbVie ABBV Stock Holding History

Signal Advisors Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.55M Buy
11,748
+5,918
+102% +$1.31M 0.18% 109
2025
Q4 		$1.33M Buy
5,830
+2,824
+94% +$643K 0.11% 162
2025
Q3 		$696K Sell
3,006
-1,789
-37% -$364K 0.06% 218
2025
Q2 		$890K Buy
4,795
+3,062
+177% +$569K 0.07% 223
2025
Q1 		$363K Buy
1,733
+91
+6% +$17.7K 0.04% 334
2024
Q4 		$292K Buy
1,642
+232
+16% +$42.7K 0.03% 367
2024
Q3 		$278K Buy
+1,410
New +$263K 0.04% 358
2024
Q2 		– Sell
-1,825
Closed -$332K – 76
2024
Q1 		$332K Buy
+1,825
New +$315K 0.08% 218

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Signal Advisors Wealth's ABBV Position: Q1 2026 in Review

Signal Advisors Wealth increased its AbbVie (ABBV) stake by 102% in Q1 2026, buying an estimated $1.31M and bringing the position to 11,748 shares worth $2.55M. The position accounts for 0.18% of the portfolio, ranked #109.

Signal Advisors Wealth first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Signal Advisors Wealth held 11,748 shares of AbbVie worth $2.55M as of Q1 2026.
  • Signal Advisors Wealth bought 5,918 AbbVie shares in Q1 2026, an estimated $1.31M.
  • AbbVie made up 0.18% of Signal Advisors Wealth's portfolio in Q1 2026, its #109 holding.
  • Signal Advisors Wealth first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Signal Advisors Wealth's 13F filing for Q1 2026, filed 17 Apr 2026.